「monoclonal」の共起表現(1語右で並び替え)

「monoclonal」の共起表現一覧(1語右で並び替え)

monoclonal

1語右で並び替え

該当件数:197件

tigen-binding (Fab or Fab') of two different monoclonal antibodies and are linked by chemical means
The term aritox occurs in names of monoclonal antibodies and indicates that they are linke
s can be screened for by flow cytometry with monoclonal antibodies to CD18 or to CD11a, b, or c.
2009, there are two fully human anti CTLA-4 monoclonal antibodies in advanced clinical trials, trem
from applying recombinant DNA technology to monoclonal antibodies and inspired the development of t
He is best known for his work on therapeutic monoclonal antibodies and their use to achieve toleranc
intended for the classification of the many monoclonal antibodies (mAbs) generated by different lab
The stem -mab is used for monoclonal antibodies as well as for their fragments, a
U.S. Patent 6,399,063 - Monoclonal antibodies directed to the HER2 receptor
U.S. Patent 5,772,997 - Monoclonal antibodies directed to the HER2 receptor
Monoclonal antibodies can distinguish between type A an
Monoclonal antibodies are potential substances for this
awarded the 1984 Nobel Prize for his work on monoclonal antibodies
CD5 was used as a T-cell marker until monoclonal antibodies against CD3 were developed.
By contrast, monoclonal antibodies are derived from a single cell li
fixation permits the detection and typing of monoclonal antibodies or immunoglobulins in serum or ur
Monoclonal antibodies are made in the laboratory and ca
e were used extensively in the production of monoclonal antibodies (MAbs).
it a suitable target for immunotherapy with monoclonal antibodies or with artificial T cell recepto
Monoclonal antibodies are monospecific, but monospecifi
Main article: Monoclonal antibodies#Production
of different capture agents, most frequently monoclonal antibodies, are deposited on a chip surface
hniques had been developed: recombinant DNA, monoclonal antibodies, and gene expression, the foundat
Anticalins are being used in lieu of monoclonal antibodies, but are about eight times smalle
Compared to other anti-HER2 monoclonal antibodies, the Fc domain of MGAH22 is optim
r bispecific antibodies, and unlike ordinary monoclonal antibodies, BiTEs form a link between T cell
Unlike monoclonal antibodies, which are often produced in mamm
tract Manufacturing Organization or (CMO) of monoclonal antibodies, recombinant proteins and vaccine
experimental drug development using blocking monoclonal antibodies, therapeutic vaccines, or siRNA t
ells for cancer therapy, cancer vaccines and monoclonal antibodies.
e one taken in the development of bispecific monoclonal antibodies.
e species marker antigens for development of monoclonal antibodies.
munologist known for his work on therapeutic monoclonal antibodies.
and Drug Administration (FDA) approved human monoclonal antibody developed by Bristol-Myers Squibb,
Iratumumab is a human monoclonal antibody used in the treatment of oncologica
so known as SGN-40 or huS2C6) is a humanized monoclonal antibody being developed for the treatment o
known as TNX-355) is a non-immunosuppressive monoclonal antibody that binds CD4, the primary recepto
Abagovomab is a mouse anti-idiotype monoclonal antibody whose variable epitope mirrors a tu
lociximab (also known as M200) is a chimeric monoclonal antibody jointly developed by PDL BioPharma
Lucatumumab is a human monoclonal antibody being investigated for the treatmen
ly human Vascular Adhesion Protein-1 (VAP-1) monoclonal antibody - intended for treatment of inflamm
it is a single chain variable fragment of a monoclonal antibody which binds to epithelial cell adhe
Kim L. O'Neill is the developer of a monoclonal antibody that allows for the accurate, cheap
ntetate (trade name Hybri-ceaker) is a mouse monoclonal antibody linked to pentetate which acts as a
rzerra, also known as HuMax-CD20) is a human monoclonal antibody (for the CD20 protein) which appear
to HER2 on the tumor cell surface, anti-HER2 monoclonal antibody MGAH22 may induce an antibody-depen
A Fc-domain optimized IgG monoclonal antibody directed against the human epiderma
ade name Zenapax) is a therapeutic humanized monoclonal antibody to the alpha subunit of the IL-2 re
Kenney had managed the monoclonal antibody (McAb) development laboratory for S
mab A/S, both of which develop drugs used in monoclonal antibody therapy.
nd Drug Administration approval of the first monoclonal antibody drug, Muronomab-CD3 (also known as
Citatuzumab bogatox (VB6-845) is a monoclonal antibody Fab fragment fused with bouganin, a
Tuvirumab is a human monoclonal antibody for the treatment of patients with
Mitumomab (BEC-2) is a mouse monoclonal antibody investigated for the treatment of s
uplizumab (trade name Antova) is a humanized monoclonal antibody intended for the treatment of rheum
vilimomab (also known as ABX-CBL) is a mouse monoclonal antibody intended for use as an immunosuppre
It was the Fab' fragment of a mouse monoclonal antibody labelled with the radioisotope indi
It consisted of an intact murine (mouse) IgM monoclonal antibody against human CD15, labeled with te
Reslizumab is a humanized monoclonal antibody intended for the treatment of eosin
PRO 140 is a humanized monoclonal antibody targeted against the CCR5 receptor
Specific diagnosis is made through monoclonal antibody testing for CR3, one of the three c
ment of Genentech's bevacizumab and Lucentis monoclonal antibody treatments.
Compared to other monoclonal antibody treatments (many of which are well
ncer that the efficacy of treatment with the monoclonal antibody cetuximab can be assessed by the ex
oduced by Genmab, as well as the first human monoclonal antibody which targets the CD20 molecule tha
t the University of Pennsylvania showed that monoclonal antibody specific to myostatin improves the
ott Laboratories) is a fully human TNF-alpha monoclonal antibody approved for the treatment of rheum
rade name Panorex) is a chimeric mouse/human monoclonal antibody to the cell-surface glycoprotein Ep
Metelimumab (CAT-192) is a human IgG4 monoclonal antibody that neutralizes TGF beta 1 which h
olecule of the drug consists of the chimeric monoclonal antibody brentuximab (which targets CD30) an
Zolimomab aritox is a mouse monoclonal antibody which has been investigated for the
The anti-TNF monoclonal antibody biologics, Infliximab and adalimuma
sted that the protein may cross-react with a monoclonal antibody that recognizes the phosphatidylser
scleroderma showed the human anti-TGF-Beta1 monoclonal antibody to be safe and well tolerated acros
% of neurons became immunoreactive to 1C2 (a monoclonal antibody against expanded polyglutamine stre
Foravirumab is a monoclonal antibody for the prophylaxis of rabies.
Bertilimumab is a human monoclonal antibody that binds to eotaxin-1.
It is a monoclonal antibody which blocks interleukin 13.
Faralimomab is a mouse monoclonal antibody and an immunomodulator.
Lumiliximab is a monoclonal antibody that targets CD23.
Clenoliximab (INN) is a monoclonal antibody against CD4.
Omalizumab is a glycosylated monoclonal antibody expressed by mammalian cells.
Rontalizumab is a humanized monoclonal antibody being developed by Genentech.
Felvizumab is a humanized monoclonal antibody against respiratory syncytial virus
CA-125 was initially detected using the monoclonal antibody designated OC125.
Anti-mesothelin monoclonal antibody MORAb-009 is a monoclonal antibody
Anti-TGF-beta monoclonal antibody GC1008 is a monoclonal antibody bei
umab (proposed USAN) is a chimeric/humanized monoclonal antibody and an immunosuppressive drug.
Minretumomab is a mouse monoclonal antibody designed for the treatment of cance
chnetium (99mTc) pintumomab (INN) is a mouse monoclonal antibody for the imaging of adenocarcinoma.
Like the monoclonal antibody belimumab, atacicept blocks the bin
Trastuzumab (INN; trade name Herceptin) is a monoclonal antibody that interferes with the HER2/neu r
Galiximab is a monoclonal antibody designed for the treatment of B-cel
The fully-human monoclonal antibody glembatumumab (CR011) is linked to
Vitaxin is a humanized monoclonal antibody against the vascular integrin avb3.
Anatumomab mafenatox is a mouse monoclonal antibody for the treatment non-small cell lu
Veltuzumab is a monoclonal antibody which is being investigated for the
y used to fuse B-cells with myeloma cells in monoclonal antibody production.
Inolimomab is a mouse monoclonal antibody developed as an immunosuppressive d
Her early work involved the application of monoclonal antibody technology to questions within neur
Fresolimumab is a human monoclonal antibody and an immunomodulator, developed b
otuzumab ozogamicin (CMC-544) is a humanized monoclonal antibody for the treatment of cancers.
Lebrikizumab is a humanized monoclonal antibody and an immunosuppresive drug for th
It is a IgG2a anti-CD20 monoclonal antibody derived from immortalized mouse cel
Teplizumab is a monoclonal antibody which is used as an immunosuppressi
Teplizumab is a humanized Fc-engineered monoclonal antibody also known as MGA031 and hOKT3γ1(Al
Sibrotuzumab is a humanized monoclonal antibody intended for the treatment of cance
Talizumab (TNX-901) is a humanized monoclonal antibody being developed by Tanox in Houston
Certolizumab pegol is a monoclonal antibody directed against tumor necrosis fac
Elsilimomab (also known as B-E8) is a mouse monoclonal antibody and an immunosuppressive drug.
Lintuzumab (SGN-33) is a humanized monoclonal antibody used in the treatment of cancer.
Tigatuzumab (CS-1008) is a monoclonal antibody for the treatment of cancer.
Pritumumab is a human monoclonal antibody used in the treatment of brain canc
Telimomab aritox is a mouse monoclonal antibody which is an immunosuppressive drug.
tuzumab (formerly EMD 72000) was a humanized monoclonal antibody for the treatment of cancer.
The monoclonal antibody tefibazumab targets ClfA and has be
Adecatumumab (MT201) is a recombinant human monoclonal antibody which is used to target tumor cells
Panobacumab (proposed INN) is a monoclonal antibody designed as an antibacterial agains
Toralizumab (IDEC 131) was a humanized monoclonal antibody and an immunosuppressive drug.
Pascolizumab is a humanized monoclonal antibody for the treatment of asthma.
Urtoxazumab is a humanized monoclonal antibody against diarrhoea caused by Escheri
Keliximab is a monoclonal antibody for the treatment of severe chronic
erimental name of an anti-HER2/neu targeting monoclonal antibody developed by MacroGenics.
Its mechanism of action is similar to the monoclonal antibody trastuzumab.
Gomiliximab is a monoclonal antibody acting as an immunosuppressive drug
and their research team first isolated this monoclonal antibody in 1981.
esilesomab (trade name Scintimun) is a mouse monoclonal antibody labelled with the radioactive isoto
e (125I) CC49 is an iodine-125 radiolabelled monoclonal antibody for the detection of tumours.
Tanezumab (INN, codenamed RN624) is a monoclonal antibody against nerve growth factor.
Tadocizumab is a humanized monoclonal antibody that acts on the cardiovascular sys
w BMS-945429) is an aglycosylated, humanized monoclonal antibody against interleukin-6.
Taplitumomab paptox is a mouse monoclonal antibody designed for the treatment of cance
Nerelimomab is a mouse monoclonal antibody acting as a TNF inhibitor.
Libivirumab is a human monoclonal antibody directed against the hepatitis B vi
Gantenerumab is a monoclonal antibody for the treatment of Alzheimer's di
CD32B may also be a target for monoclonal antibody therapy for malignancies.,
Vepalimomab is a mouse monoclonal antibody developed for the treatment of infl
Tenatumomab is a monoclonal antibody designed for the treatment of cance
Lemalesomab is a mouse monoclonal antibody for the diagnosis of inflammatory l
cilimumab, CP-675,206) is a fully human IgG2 monoclonal antibody produced by Pfizer.
It is a fusion protein of a humanized monoclonal antibody (tucotuzumab) and an interleukin-2
monoclonal antibody therapy- e.g., mepoluzimab or resli
) imciromab (trade name Myoscint) is a mouse monoclonal antibody labelled with the radioisotope Indi
ibutions to improvements and developments in monoclonal antibody technology-especially focusing on t
Sevirumab (MSL-109) is a human monoclonal antibody for the treatment of infections wit
under the trade name LymphoScan) is a mouse monoclonal antibody labelled with the radioactive isoto
Pagibaximab is a chimeric monoclonal antibody for the prevention of staphylococca
It is a single chain variable fragment of a monoclonal antibody targeted against component 5 of the
Ramucirumab is a fully-human monoclonal antibody (IgG1) directed against the Vascula
gis which is manufactured by MedImmune) is a monoclonal antibody produced by recombinant DNA technol
(trade name Rexomun) is a rat-murine hybrid monoclonal antibody designed to treat some types of can
Cantuzumab mertansine is a humanized monoclonal antibody used to treat colorectal cancer and
the trade name CEA-CIDE) is a humanized IgG1 monoclonal antibody for the treatment of colorectal can
is a Fab' fragment of IMMU-4, a murine IgG1 monoclonal antibody extracted from the ascites of mice.
Lerdelimumab (CAT-152) is a human monoclonal antibody and an immunosuppressive drug devel
Afutuzumab is a monoclonal antibody being developed by Hoffmann-La Roch
Monoclonal antibody technology combined with recombinan
wn as LeukArrest and Hu23F2G, is a humanized monoclonal antibody which was an experimental immunosup
The drug is a monoclonal antibody that suppresses white blood cells w
is a recombinant DNA-derived humanized IgG1k monoclonal antibody that selectively binds to human imm
Solanezumab (proposed INN) is a monoclonal antibody being investigated as a neuroprotec
Olaratumab is a monoclonal antibody which is being developed by Imclone
eted under the trade name OvaRex) is a mouse monoclonal antibody it binds to the antigen CA125, a ca
under the brand name Aurexis) is a humanized monoclonal antibody for the treatment of severe infecti
Edobacomab, codenamed E5, is a mouse monoclonal antibody that was investigated as a possible
She pioneered the use of monoclonal antibody technology in brain research and di
The monoclonal antibody (for CD22) is linked to a cytotoxic
proposed trade name Bosatria) is a humanized monoclonal antibody that recognizes interleukin-5 (IL-5
Golimumab (CNTO 148) is a human monoclonal antibody which is used as an immunosuppressi
Anti-mesothelin monoclonal antibody MORAb-009 binds to mesothelin (a pr
preclinical studies of its agent Angiolix, a monoclonal antibody that binds to lactadherin and inhib
so known as ETR2-ST01) is an agonistic human monoclonal antibody against TRAIL-R2 (DR5, APO-2) used
), which was identified by reactivity with a monoclonal antibody, is present on monocytes, neutrophi
is a combination of bivatuzumab, a humanized monoclonal antibody, and mertansine, a cytotoxic agent.
Epratuzumab is a humanized monoclonal antibody.
Ocrelizumab is a humanized anti-CD20 monoclonal antibody.
Ramucirumab (IMC-1121B) is a fully human monoclonal antibody.
Afelimomab (MAK 195F) is an anti-TNFα monoclonal antibody.
lly, it is a pegylated F(ab')2 fragment of a monoclonal antibody.
suffix -zumab, it is a recombinant humanized monoclonal antibody.
oposed INN, trade name Numax) is a humanized monoclonal antibody.
d Fab' fragment of a humanized TNF inhibitor monoclonal antibody.
e Nuvion, PDL BioPharma Inc.) is a humanized monoclonal antibody.
(cMT 412) is a human-mouse chimeric anti-CD4 monoclonal antibody.
a single-chain variable fragment of a human monoclonal antibody.
(also called 2C4, trade name Omnitarg) is a monoclonal antibody.
Monoclonal gammopathy of undetermined significance can
Abnormal bands (spikes) are seen in monoclonal gammopathy of undetermined significance and
ith CG due to hematological malignancies and monoclonal immunoglobulins.
Monoclonal paraprotein: In most cases a serum paraprote
sis is sufficient to screen for pathological monoclonal plasmaproliferative disorders other than AL
s, causing self-stimulation and ultimately a monoclonal population of T cells.
light chain are known as paraproteins or M ( monoclonal) proteins.
864.4020 as “antibodies, both polyclonal and monoclonal, specific receptor proteins, ligands, nuclei
myc, HA), where a monoclonal was first isolated against an existing prote